ARCHIVES

NKTR-102 Shows 29 Percent Response in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: House Fills Subcommittee Positions; Senate Schedules NCI Appropriations Hearing Feb. 18

February 13, 1981

ASCO Urges Increase In Research Funding, Removal of Barriers For Trial Participation

January 23, 2009

Fox Chase-U.Pa. Radiation Dept. Received Contract

October 12, 1979

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Chemo+Radiation Preserves Voice, RTOG Study Finds

December 26, 2003

NCI Advisory Group, Other Cancer Meetings For April, May

March 26, 1976